New Targets for SARS/MERS Drugs - ICAAC 2014
1,362 views · Published 22 February 2016 · 25:57 · Indexed 6 November 2026
Channel: ASM - Microbes Make Our World · 2016 · Science & Technology
Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing an expanding epidemic of a “SARS-like” illness in the Middle East with exported cases to the United States, Europe, Asia, and Africa. Reports of human-to-human transmission of MERS-CoV in healthcare facilities and close family contacts have raised global concern about its pandemic potential. Unfortunately there are currently no antiviral agents approved for treatment of MERS or SARS. Researchers will discuss late-breaking research on a newly identified candidate compound as well as other options for treatment currently in the pipeline. Hao Lei, University of Illinois at Chicago Hyun Lee, University of Illinois at Chicago Jasper Chan, University of Hong Kong
More from this channel
-
4:18
Curbing Climate Change with Algae - Cultures Digital Feature
-
29:36
An Epidemiological Survey of Toothbrush Contamination in Communal Bathrooms - ASM Live 2015
-
29:28
The Effect of Agion Silver Technology on the Bacterial Populations Found on Door Handles
-
26:25
Antibiotic Stewardship: Saving Drugs, Saving Money - ICAAC 2014
-
30:17
Co-contribution of rotavirus and pneumococcal vaccines in reduction of pediatric hospital burden
-
27:12
Bordetella parapertussis Outbreak in Southeastern Minnesota in 2014 - ICAAC 2015
-
41:26
Emerging Answers from the Ebola Outbreak - ICAAC 2014
-
1:02:01
ASM ¡en vivo! 2014